CJC-1295 Ipamorelin peptide therapy is a subcutaneous injection given multiple times a week to increase growth hormone levels and cellular repair. This medical weight loss treatment can help increase energy levels, lean muscle mass, fat loss, and body performance.
CJC-1295 and Ipamorelin are synthetically produced peptides that stimulate growth hormone release from your pituitary gland. This peptide therapy combines both treatments to facilitate elevated growth hormone production in your body and improve cellular repair, allowing your muscle tissue to grow. Growth hormone-releasing peptides can be a great alternative to growth hormone treatments, with fewer side effects and the same awesome benefits.
Peptides like CJC-1295 and Ipamorelin are chains of amino acids that work to release weight loss-stimulating growth hormones in the body.
This growth hormone therapy comes in the form of a subcutaneous peptide injection in the lower stomach, thigh, or upper arm. For the best results, CJC-1295 Ipamorelin should be injected 5 out of 7 days a week. This schedule allows the pituitary gland to restore its growth hormone levels on the days without injection. With consistent treatment, you can make progress on your weight loss journey towards your health and wellness goals. You can rely on the capable, compassionate team at our McAllen peptide therapy clinic and med spa for a personalized treatment plan and exceptional care.
This growth hormone-releasing hormone can be especially beneficial for those over 30 because, at that age, the body’s growth hormone levels tend to drop. If you’re also looking to lose weight and see muscle growth, this treatment works well in conjunction with a proper diet and exercise program.
While CJC-1295 Ipamorelin peptide therapy is relatively low-risk, you’ll still need a prescription to get started. If you have any past or current medical conditions or are taking other medications, you should speak to your physician at Uptown Medical Wellness & Anti-Aging Center to make sure this is a safe option.
